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Background: Aggregatibacter actinomycetemcomitans produces a leukotoxin that activates a pro-inflammatory
death of human monocytes/macrophages. A specific clone of this bacterium (JP2) has a 530-base pair deletion in
the leukotoxin promoter gene and significantly enhanced expression of leukotoxin. This specific clone of
A. actinomycetemcomitans is common in some African populations and has a strong association with periodontal
attachment loss in adolescents in these populations. Chewing sticks of plant origin are commonly used as oral
hygiene tool in Africa, but their role as a therapeutic agent in periodontal disease is poorly investigated.
Results: Ethanol extracts were made from 7 common plants used as chewing sticks in West-Africa. None of the
tested extracts inhibited growth of A. actinomycetemcomitans. However, extracts from Psidium guajava (Guava)
completely neutralized the cell death and pro-inflammatory response of human leukocytes induced by the
leukotoxin. None of the six other tested chewing stick extracts showed this effect.
Conclusions: The discovery that extracts from Guava efficiently neutralizes A. actinomycetemcomitans leukotoxicity
might lead to novel therapeutic agents and strategies for prevention and treatment of aggressive forms of
periodontitis induced by infections with the highly leukotoxic JP2 clone of this bacterium.Background
Aggregatibacter actinomycetemcomitans has been described
as a member of the indigenous oral microbiota of humans,
and it is involved in the pathology of periodontitis and
various non-oral infections [1]. This bacterium selectively
kills human leukocytes through expression of leukotoxin, a
large pore-forming protein that belongs to the RTX family
[2,3]. The specificity of the toxin is related to its pre-
requisite for a specific target-cell receptor, the lympho-
cyte function associated antigen 1 (LFA-1), which is solely
expressed on leukocytes [4]. The leukotoxin causes death
of different leukocyte populations in a variety of ways. It
activates a rapid release of lysosomal enzymes and matrix
metalloproteinases from neutrophils and causes apoptosis
in lymphocytes [5-7]. In monocytes/macrophages, the toxin
activates caspase-1, a cysteine proteinase, which causes a* Correspondence: anders.johansson@odont.umu.se
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reproduction in any medium, provided the orpro-inflammatory response by the activation and secretion
of interleukin (IL)-1β and IL-18 [8-10]. These cellular and
molecular activations are associated with the pathogenic
mechanism of periodontitis, which results in loss of tooth-
supporting tissues, bone and connective tissue [8,11]. A
specific clone (JP2) of A. actinomycetemcomitans with
enhanced leukotoxin expression is significantly associated
with disease onset in infected individuals [12]. The JP2
clone is likely to have its origin in the Mediterranean part
of Africa, but today it can be found occasionally also in
South and North America and in Europe [13-15].
It has recently been shown that the occurrence of JP2
clone strains of A. actinomycetemcomitans in Ghanaian
adolescents is high [16]. In this part of the world, the use
of chewing sticks from different tree species has a long
tradition as a tool for oral hygiene practices [17,18]. The
sticks are chewed for mechanical removal of tooth
plaque, but some plants used for this purpose might also
have antimicrobial properties [19-22].
The aim of the present study was to evaluate if some
of the commonly used chewing stick materials in Ghanal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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None of the seven tested chewing stick extracts showed
any growth inhibitory effect on A. actinomycetemcomi-
tans in either of the two in vitro test methods employed
in the present study, growth on agar or growth in broth.
Two different strains of this bacterium were used (D7SS
and HK1519), in order to represent both JP2 and non-
JP2 clonal types of A. actinomycetemcomitans. No inhib-
ition zones were seen when 10 μl from each of the 7
concentrated stick extracts was added to agar plates
inoculated with D7SS and HK1519. Also, no inhibitory
effects on growth of these two strains were seen when
≥1% from each concentrated stick extracts were added
and optical density was followed continuously during
48 h in the broth cultures.
Neutralization of leukotoxin-induced cell death
When the different chewing stick extracts were added to
human mononuclear leukocytes that were exposed to
A. actinomycetemcomitans leukotoxin, the induced LDH
release was completely inhibited in samples containing
0.1% Guava twig extract (Figure 1). None of the other 6
extracts inhibited leukotoxicity at the concentration used
(0.1%) in the present assay. The chewing sponge extract
also caused LDH release in the absence of leukotoxin.


















Figure 1 Guava extracts block the leukotoxin-induced
leukocyte lysis. LDH-release from human mononuclear leukocytes
exposed to A. actinomycetemcomitans leukotoxin (100 ng/ml) for
60 min with or without extracts (0.1%) from different chewing stick
materials. Representative results are shown.highly leukotoxic A. actinomycetemcomitans, cell death
was examined with propidium iodide staining documen-
ted by flow cytometry. These analyses further indicated
the leukotoxin-neutralizing capacity of the Guava twig
extract, while none of the other tested extracts signifi-
cantly inhibited the leukotoxicity (p = 0.006) (Figure 2).
Chewing sponge alone also showed cytotoxic activity in
this assay.
Morphological analyses of leukotoxin-exposed human
leukocytes by flow cytometry showed that polymorpho-
nuclear leukocytes (PMNs) and monocytes were sensitive
targets for the leukotoxin (Figure 3A). These morpho-
logical alterations induced by the leukotoxin were com-
pletely abolished in the presence of Guava extract (0.1%).
Propidium iodide staining of the exposed leukocytes fur-
ther indicated the protective effect of the Guava extract.
In a first attempt to localize the presence of the respon-
sible compounds in the plant, extracts from fruit and
leaves were also examined. Extracts from leaves (0.1%)
and twigs (0.1%) showed similar leukotoxin-neutralizing
capacity, while the fruit extract (0.1%) completely lacked
such capacity (Figure 4). A dose–response experiment
showed that the extract from the twigs had a higher cap-
acity to neutralize leukotoxin than the extracts from the
leaves (Figure 4B).
In order to validate the stability of the results, extracts
from Guava plants were made from materials collected both
in the Greater Accra and the Volta regions of Ghana. The
















Figure 2 Leukocytes survive exposure to highly leukotoxic
A. actinomycetemcomitans in the presence of Guava. Viability
(propidium iodide-(PI) uptake) of human mononuclear leukocytes
exposed to A. actinomycetemcomitans from the highly leukotoxic
strain HK1519 in a ratio of 10 bacteria/leukocyte for 60 min in
presence or absence of extracts (0.1%) from different chewing stick
materials. The proportion of PI-stained dead cells was quantified by
flow cytometry analyses. Mean ± SD of 3 experiments is shown and






















Figure 3 Leukotoxin-induced morphological alterations in monocytes and neutrophils are abolished in the presence of Guava extract.
Human leukocytes exposed to A. actinomycetemcomitans leukotoxin (100 ng/ml) for 60 min with or without extracts (0.1%) from Guava twigs. Cell
morphology of the different exposed leukocyte subsets (FSC/SSC) was documented by flow cytometry analyses (A). Viability (PI-uptake) in the
exposed leukocyte populations was quantified by flow cytometry analyses (B). Black line represents control cells, green line leukotoxin-exposed
cells and the violet line cells exposed to leukotoxin in the presence of Guava extract. Representative dot plots and histogram are shown.
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leukotoxin.Neutralization of leukotoxin-induced pro-inflammatory
response
A. actinomycetemcomitans leukotoxin induces a rapid re-
lease of IL-1β from human leukocytes. The Guava extract
(0.1%) efficiently inhibited (p ≤ 0.001) the release and acti-
vation of IL-1β that is induced in the presence of cytolytic
concentrations of leukotoxin (100 ng/ml) (Figure 5A & C).On the contrary, the release of IL-1β caused by the leuko-
toxin mutant A. actinomycetemcomitans (D7SSΔltxA) that
lacks leukotoxin was not interfered by the Guava extract
(Figure 5B & D). This indicates a specific effect on the leu-
kotoxin-induced leukocyte activation.Target identification of the Guava leukotoxin-neutralizing
compounds
To determine if the target molecules for the leukotoxin



























































Figure 4 The leukotoxin-neutralizing compounds of Guava are present in leaves and twigs, but not in the fruit. (A) LDH-release from
human leukocytes exposed to A. actinomycetemcomitans leukotoxin (0, 80, or 240 ng/ml) for 60 min in the presence of Guava extracts (0.1%) from
twigs, leafs or fruits. Representative results of relative LDH release are shown. (B) Leukotoxin neutralizing capacity in different concentrations of
Guava extracts (twigs, leafs, fruits) based on LDH-release from macrophages exposed to leukotoxin (80 ng/ml) for 60 min. Mean ± SD of 3
observations is shown.
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to Guava extracts. A. actinomycetemcomitans from the
highly leukotoxic strain (HK1519) lost its leukotoxic activ-
ity (p ≤ 0.001) when pre-exposed to Guava extracts that
were washed away before A. actinomycetemcomitans were
added to the leukocytes (Figure 6). In addition, Guava
extracts used for pre-exposure of leukotoxic bacteria lost
their leukotoxin-neutralizing capacity. Leukocytes pre-
exposed to Guava extract that was removed before addition
of leukotoxin were still leukotoxin-sensitive. These results
indicate that compounds in the Guava extract neutralize
the leukotoxin by binding directly to the leukotoxin and
not to the target leukocytes.Oral hygiene habits of Ghanaian adolescents
Among the 296 examined individuals, 295 used toothbrush
and toothpaste daily for oral hygiene (Table 1). Further-
more, 56.4% of these adolescents also used chewing sticks
from different plant materials for the same purpose. The
most commonly used materials were Sokodua and Nim
tree, which were used by 48% and 28.6%, respectively.
Guava was used by 11.4% of the chewing stick users, which
corresponded to 6.4% in the whole examined population.
Discussion
The present study shows that an extract from Guava









































































Figure 5 Guava extracts neutralize leukotoxin-induced pro-inflammatory response, but not the bacteria-induced response. LDH-release
(A & B) and IL-1β secretion (C & D) of human leukocytes exposed to A. actinomycetemcomitans leukotoxin (100 ng/ml) (A & C) or bacteria from
the leukotoxin mutant strain D7SSΔltxA (10 bacteria/leukocyte) (B & D) for 60 min. Mean ± SD of 3 experiments is shown and significant
leukotoxin neutralization is indicated (*).
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temcomitans leukotoxin. Compounds in the Guava extract
















Figure 6 The leukotoxin-neutralizing compounds bind to the
bacteria-associated toxin upon neutralization. LDH-release from
macrophages (PMA-treated THP-1 cells) exposed to highly leukotoxic
A. actinomycetemcomitans (strain HK1519) 10 bacteria/cell for 60 min.
The macrophages were exposed to native bacteria, bacteria pre-
treated with Guava extract (0.1%) or to bacteria in the presence of
Guava (0.1%). Mean ± SD of 3 experiments is shown and significant
leukotoxin neutralization is indicated (*).and completely abolishes its biological activity. Highly leu-
kotoxic A. actinomycetemcomitans are frequently found in
adolescents with periodontitis in some populations [23].
The highly leukotoxic JP2 clonal type of this bacterium
has its origin from North- and West Africa, and a high
prevalence of JP2 clone strains has been found in popula-
tions in this particular geographic area [13,16]. Data from
the present study show that traditional chewing sticks are
commonly used tools for oral hygiene practices in Ghana.
More than 50% in the examined population reported daily
use of chewing sticks obtained from different plants. The
source of chewing stick material differs among subjects of
various ethnicity and geographic origin [17]. The propor-
tion of subjects who select Guava as source for chewing
sticks was only 6.4% in the examined population, which is
in line with previously presented data by Adu-Tutu and
co-workers 1979 [17]. Our discovery that Guava releases
components that neutralizes the activity of A. actinmyce-
temcomitans leukotoxin might be used in future prevent-
ive strategies in some populations. Several plants used as
chewing stick material show antimicrobial activity against
several bacterial species [20,21]. However, none of the
plant extracts used in the present study inhibited growth
of A. actinomycetemcomitans.
Guava (Psidium guajava) is grown in tropical and sub-
tropical countries for food, but it is also widely used in












1 time/day 94 (31.8%)
2 times/day 202 (62.2%)
Two hundred and ninety six (296) students at Kpandu Technical Institute,
located in the Volta-region of Ghana, were examined.
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intestinal and respiratory disturbances and as an anti-
inflammatory agent [25]. The ethanol extract of Guava
leaves contains polyphenols, which have reported anti-
oxidant, anti-cancer, anti-inflammatory and anti-allergic
activities [26]. In addition, Guava extract contains com-
pounds with anti-microbial activity, such as flavonoids,
steroids, and tannins [27]. Since these compounds are
commonly present in several plant species [28], the
Guava-specific leukotoxin-neutralizing activity might
be the result of a yet unknown compound. The molecu-
lar properties of the leukotoxin, such as the high iso-
electric point (8.9), hydrophobic and hydrophilic regions,
and the repeat region, mediate several binding targets
for bioactive molecules [2]. This molecular structure of
A. actinomycetemcomitans leukotoxin is shared by a num-
ber of proteins from the RTX family that are produced by
a number of different Gram negative human pathogens [3].
This indicates that the bioactive leukotoxin-neutralizing
components of Guava may also be used to inhibit the ac-
tivity of RTX proteins from bacterial species other than
A. actinomycetemcomitans.
Methods and tools for oral hygiene vary from country
to country and from culture to culture. Despite the wide-
spread use of toothbrushes and toothpastes, traditional
methods of tooth cleaning using chewing sticks selected
and prepared from the twigs, stems or roots from a var-
iety of plant species have been practised for thousands of
years in Asia, Africa, the Middle East, and the Americas
[18]. Today, chewing sticks are used in many developing
countries because of religion and/or tradition, and be-
cause of their availability, low cost, and simplicity [29].
In our recent investigation we found that >50% of the
sample population in the Volta region of Ghana daily
used chewing sticks for their oral hygiene. The consen-
sus report on oral hygiene year 2000 stated that chewingsticks may have a role to play in the promotion of oral
hygiene, and that evaluation of their effectiveness war-
rants further research [18].
The occurrence of the highly leukotoxic clone (JP2) of
A. actinomycetemcomitans coincides geographically with
the use of chewing sticks as tools for oral hygiene [23,29].
Our recent discovery of the unique property of Guava to
release components that efficiently neutralize leukotoxin
might be used in future strategies for periodontal treat-
ment in these populations. This study shows for the first
time that the selection of a particular plant for chewing
stick might be of great importance in terms of having a
therapeutic potential. The use of Guava as the source of
the chewing stick material is not common in these popula-
tions [17], but was used by 5.6% of the examined Ghanaian
population in the present study. However, it remains to
be elucidated if neutralization of leukotoxin is an effi-
cient treatment strategy for the aggressive form of peri-
dontitis that is induced by the inflammatory response to
the highly leukotoxic A. actinomycetemcomitans. Fur-
thermore, a future aim will be to isolate the components
in the Guava extract that are responsible for the leuko-
toxin neutralization. The clinical importance of the
present discovery can be evaluated in parallel with the
isolation of the active compounds. The history of Guava
as source for medical treatments in traditional medicine
indicates a low risk for negative side effects [25]. In
addition, the results in the present study showed that
Guava had no cytotoxic effects against the exposed
human leukocytes. The Guava chewing stick can be the
source of the leukotoxin-neutralizing compound, a well
known and easily accessible tool for oral hygiene in
many of the developing countries.
Conclusions
The leukotoxin-neutralizing properties of Guava might
be an important finding due to the high prevalence of
highly leukotoxic A. actinomycetemcomitans in African
countries where this plant material is easily available and
used as an oral hygiene tool.
Methods
Bacterial cultures
In this study the following A. actinomycetemcomitans
bacterial strains were used: A. actinomycetemcomitans
strain HK 1519 (JP2 clone strain) and the D7SS strain
with a complete leukotoxin promoter (non-JP2 clonal
strain). In one experiment the leukotoxin knockout mu-
tant strain D7SS ΔltxA was used. The enhanced leuko-
toxin production of the JP2 clone is about 10 fold higher
than the production of non-JP2 strains [9]. The A. acti-
nomycetemcomitans strains were cultivated on blood
agar plates at 37°C in aerobic atmosphere containing 5%
CO2. After 72 h incubation the bacteria were harvested
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NaCl. The optical density (OD600) was measured, and
the bacteria were suspended in phosphate buffered sa-
line (PBS) at different concentrations.
Leukotoxin and leukocyte preparations
Leukotoxin was purified from A. actinomycetemcomitans
strain HK 1519, described in details previously [30]. The
purified leukotoxin was basically free from lipopolysac-
charides (LPS) (<0.001% of total protein) and visualized
by SDS-polyacrylamide gel separation.
Human leukocytes were isolated from an enriched
leukocyte fraction (buffy coat) of venous blood (from
blood donors at the University Hospital blood bank in
Umeå, Sweden), as described previously [9]. Mononuclear
leukocytes (MNLs) were isolated by isopycnic centrifuga-
tion in LymphoprepW (Nycomed AB, Lidingö, Sweden).
The fraction containing MNLs was collected, and the cells
were washed 3 times with PBS (250 x g, 5 min) to remove
platelets. The cell pellet was then re-suspended in culture
medium RPMI-1640 containing L-glutamine, 10% foetal
bovine serum (FBS), and Penicillin-Streptomycin (Sigma-
Aldrich, St Louis, MI, USA) to yield 5 x 106 cells/ml. In
addition, in some experiments, Macrodex (Meda AB,
Solna, Sweden) separation was used in order to isolate the
leukocytes from the blood. This leukocyte fraction also
contained neutrophils, and the procedure was performed
as described earlier [9].
Cell cultures
Cells of the human acute monocytic leukemia cell line
THP-1 (ATCC 16) were cultured in RPMI-1640 (Sigma-
Aldrich, St Louis, MI, USA) with 10% foetal bovine
serum (FBS) (Sigma-Aldrich) at 37°C in 5% CO2. Before
determination of leukotoxic activity, the THP-1 cells
were seeded in 96-well cell-culture plates at a cell density
of 5 x 105 cells/ml in 100 μl culture medium supplemen-
ted with 50 nM phorbol 12-myristate 13-acetate (PMA,
Sigma-Aldrich) and incubated for 72 h. The PMA-acti-
vated THP-1 cells exhibited adherent properties and
enhanced sensitivity to the leukotoxin. Twenty-four h
prior to leukotoxin exposure, the culture medium was
discarded and 50 μl fresh medium without PMA was
added to each well of the THP-1 monolayer
Preparation of chewing stick extracts
Ethanol extracts from 7 different plant materials was per-
formed by mixing minced plant materials with 70% etha-
nol (250 mg/ml). The mixtures were then gently agitated
for 24 h before the insoluble material was removed by
centrifugation (5 000 x g, 20 min), and the supernatants
were frozen in aliquots at - 20°C before use. Twigs were
studied from seven chewing stick sources: (1) Tropical
almond (Terminalia catappa), (2) Guava (Psidiumguajava), (3) Blackberry (Rhus), (4) Nim tree (Azadir-
achta), (5) Sokodoa (Garcinia) family 1 and (6) family 2,
and (7) chewing sponge (cellulose fibres of unspecified
origin of spongy texture). Dry weight for the different
extracts were in mg/ml; 1 = 8.9, 2 = 5.0, 3 = 2.5, 4 = 6.7,
5 = 5.9, 6 = 9.0 and 7 = 15.6. The twigs, including bark,
were 4–8 mm in diameter and minced into pieces of
about 1 x 1 mm before the extraction procedure. All
extract revealed a strong yellow to green colour that
was completely clear and without enhanced viscosity
after the centrifugation. Leafs and fruits from Guava
were also studied and extracted with the same proced-
ure. The leaf extracts had a green colour and a dry
weight of 10.0 mg/ml and the fruits revealed a light
yellow colour in the extract with a dry weight of
3.5 mg/ml.
The 7 different chewing stick materials were initially
collected from the Accra region of Ghana. A second col-
lection of material solely from Guava was made in the
Volta region of Ghana and contained twigs (including
bark), leaves and fruits from this plant. This was made in
order to check that the biological effect was associated
to the Guava-plant and not to the growth conditions. In
addition, the identification of the Guava plant was made
by different individuals, which made the selection of ma-
terial completely independent of each other in the first
and the second collection procedure.Antimicrobial test
The different plant extracts were examined for possible
inhibition of A. actinomycetemcomitans (strain HK1519
and D7SS) growth by 2 different methods.
Inhibition of A. actinomycetemcomitans growth on
agar
One hundred μl of a bacterial suspension (2x109
cells/ml) was spread on a blood agar plate with a sterile
cotton swab, and then 10 μl of each extract was added.
The plates were then cultured for 48 h at 37°C in 5%
CO2 in air and the inhibition zones were examined in a
microscope. Ten μl of 70% ethanol was used as a nega-
tive control.
Inhibition of A. actinomycetemcomitans in broth
One μl of a bacterial suspension ( 2 x 109 cells/ml),
99 μl culture broth (peptone-yeast extract-glucose broth)
[30] and 1 μl of the different stick extracts were put into
96-well culture plates. This yielded a final concentration
of 1% extract in each well with broth cultured bacteria.
The mixtures were then cultured for 48 h at 37°C in 5%
CO2, and the optical density (OD) at 600 nm was docu-
mented automatically in a spectrophotometer. The in-
crease in OD in each mixture was compared with that in
a sample with 1% ethanol instead of a plant extract, and
the % inhibition caused by the extracts was calculated.
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The leukocyte preparations or THP-1 cells were mixed
with the different extracts (≤0.1%) before leukotoxin
(100 ng/ml) or leukotoxic bacteria (HK1519 10/cell)
were added.Cytolysis
Leukotoxin-induced cytolysis was determined by the re-
lease of the cytosol enzyme lactate dehydrogenase (LDH)
as described earlier [30]. The cells were incubated for
60 min at 37°C in the presence of various concentrations
of leukotoxin. The activity of the enzyme released from
damaged cells into the supernatant was measured and
expressed as a percentage of the total LDH activity
released from cells lysed by exposure to 0.1% Triton X-
100 for 60 min. In some experiments normalized values
are shown with the spontaneous release from leukocytes
in the control cultures set to 1.0. The different extracts
alone had no effect on the activity of LDH when they
were added to the positive control.Propidium iodide (PI) uptake quantified by FACS
(fluorescence assisted cell sorter)
The leukocytes were incubated in culture medium for
60 min at 37°C in the presence of 1 or 10 ng/ml A. acti-
nomycetemcomitans leukotoxin. Leukocytes in plain cul-
ture medium served as controls. These cells were further
analyzed for early detection of apoptosis/necrosis. The
experiment was ended on ice and PI was added accord-
ing to the VybrantW Apoptosis Assay Kit #4 protocol
(Molecular Probes/Invitrogen Labelling and Detection,
Eugene, Oregon, USA). The cells were incubated for
30 min and transferred to FACS tubes and analyzed by
FACS as soon as possible using 488 nm excitation with
fluorescence emission at 575 nm (e.g., FL3) (Calibur,
Becton Dickinson Immunocytometry Systems, CA, USA).
Dead cells stained positive for PI, and the proportion was
calculated from the results of 10 000 cells in each sample.
In addition, the different subsets of leukocytes (lym-
phocytes, monocytes and neutrophils) were identified
through their specific pattern in forward- and side scat-
ter of a FACS dot-plot. This gives an overview of which
subsets of leukocytes were attacked by the leukotoxin
and protected by chewing stick extract.Cytokine quantification
Enzyme-linked immunosorbent assay (ELISA)
The macrophages were exposed to bacterial stimuli as
described above. The amounts of IL-1β secreted into the
culture medium were determined by ELISA (Enzyme
Linked Immuno Sorbent Assay) using DuoSet kits (R&D
Systems Inc, Minneapolis, MN, USA). The experimental
procedures were done according to the manufacturer’sprotocol. This assay recognizes specifically the cleaved
17-kDa active form of IL-1β.
Oral hygiene habits in Ghanaian adolescents
Two hundred ninety-six adolescents at the Kpandu Tech-
nical Institute in the Volta region of Ghana were inter-
viewed about oral hygiene habits. They were 16–29 years
of age, median age 19 years. The interview was made with
a questionnaire and a brief clinical field examination of
general oral health. Data from this survey was used only
for to get an overview about chewing sticks usage and
source of plant materials for the sticks in this population.
Ethics
Blood was taken from donors visiting the University Hos-
pital blood bank in Umeå, Sweden. Informed written ap-
proval was given by all subjects, and authorization for the
study was granted by the Human Studies Ethical Commit-
tee of Umeå University, Sweden (}67/3, dnr 03–019). Eth-
ical clearance for field studies in Ghana was approved by
the University of Ghana (NMIMR-IRB CPN 049/08-09).
Statistics
Student t-test was used to evaluate significant differ-
ence between tested samples and corresponding con-
trols. P-values ≤0.05 were considered as significant
differences between samples.
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